Help Sitemap Home Skip Navigation Contact Us Disability Statement

 
 
Saturday, 10th May 2008

Premium Article !

Your account has been frozen. For your available options click the below button.

Options

Premium Article !

To read this article in full you must have registered and have a Premium Content Subscription with the News Letter site.

Subscribe

Registered Article !

To read this article in full you must be registered with the site.

Infectious disease project wins national award



Click on thumbnail to view image
Click on thumbnail to view image
Click on thumbnail to view image
Click on thumbnail to view image
Click on thumbnail to view image

A PROJECT between Northern Ireland scientists and biotech firm Fusion Antibodies has earned Queen's University a national award marking cooperation between academia and industry.
The project which speeds up the production of a diagnostic kit for infectious diseases has won the Knowledge Transfer Partnership Northern Ireland regional award in recognition of KTP Associate Dr Henry Kwok’s work in developing the partnership betwe
en Fusion and the School of Pharmacy which began in 2004.

His work has enabled Fusion to produce protein from a target DNA sequence within a third of the usual time for use in a range of applications in basic research, diagnostics and therapeutics.

“The project was an excellent opportunity to work collaborating with Fusion Antibodies,” said research leader Dr Chris Scott.

“These proteins can be used in the battle against infectious diseases and the development of cancer diagnostics and therapeutics. Plans are under way to produce the kit commercially.

“This is an excellent example of the way in which Queen’s can help to produce jobs and revenue in Northern Ireland.”

Dr Shane Olwill, of Dunmurry-based Fusion Antibodies, said the KTP programme had allowed the firm to overcome bottlenecks in production capabilities.

“Our partners at Queen’s introduced some key improvements allowing scale-up of protein production in a cost-effective manner.”

Fusion Antibodies was itself established in 2001 as a spin-off from Queen’s when it was established to service the market for antibodies for researchers.

KTP is a UK wide programme funded by 18 organisations and headed by the Technology Strategy Board, a business-led executive non-departmental public body.

The programme aims to increase the interaction between businesses and academic institutions and provides company based training for recently qualified people to enhance their business and specialist skills.

Queen’s is the biggest participant of KTP in the UK with 42 live programmes at present.

Commenting on his award Dr Kwok said the programme had allowed him “a unique chance to develop my scientific career by working in both industrial and academic environments which gave me a chance to learn valuable managerial and technical experience”.



The full article contains 358 words and appears in News Letter newspaper.
Page 1 of 1

  • Last Updated: 26 March 2008 6:23 PM
  • Source: News Letter
  • Location: Belfast
 
 
  

 
 


Sister Newspapers:
Press Complaints Commission

This website and its associated newspaper adheres to the Press Complaints Commission’s Code of Practice. If you have a complaint about editorial content which relates to inaccuracy or intrusion, then contact the Editor by clicking here.

If you remain dissatisfied with the response provided then you can contact the PCC by clicking here.